Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables.
Marco PitteriRoberta MagliozziAlbulena BajramiValentina CameraMassimiliano CalabresePublished in: Expert opinion on pharmacotherapy (2018)
Fingolimod might have a significant neuroprotective effect on relapsing remitting MS based on its modulatory effect on oligodendroglial cells and astrocytes, and on its direct effect on cortical neurons. Future clinical studies including measures of grey matter damage are required to confirm in vivo such neuroprotective effect.